Skip to main content
. Author manuscript; available in PMC: 2019 Apr 23.
Published in final edited form as: Expert Rev Vaccines. 2017 Oct 23;16(12):1203–1216. doi: 10.1080/14760584.2017.1393337

Figure 1.

Figure 1.

Annual expenditures of the Global Polio Eradication Initiative (GPEI), Measles & Rubella Initiative (M&RI) and Gavi, the Vaccine Alliance* (Gavi), 2001–2016.

Data sourced from: http://polioeradication.org/Financing. http://measlesrubellainitiative.org/. Midterm Review of the Measles and Rubella Global Strategic Plan, 2012–2020.

*Represents measles-related Gavi expenditures. Not shown here, approximately US$800 million available to Gavi-eligible countries during 2016–2020, approved by the Gavi Board in December 2015, as part of a new Gavi comprehensive measles and rubella strategy.